SCHEMBL8910002

SCHEMBL8910002

O=[N+]([O-])c1ccc(/N=N/c2c(O)cccc2O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.60
KMT2A Q03164 9/20 0.60
MAPT P10636 6/20 0.60
RAB9A P51151 4/20 0.60
NPC1 O15118 3/20 0.60
NPSR1 Q6W5P4 2/20 0.60
TDP1 Q9NUW8 2/20 0.60
MAPK1 P28482 2/20 0.60
HSP90AA1 P07900 2/20 0.60
RECQL P46063 1/20 0.60
ALDH1A1 P00352 5/20 0.56
POLB P06746 4/20 0.56
HTT P42858 2/20 0.56
LMNA P02545 1/20 0.56
GAA P10253 3/20 0.56
GLA P06280 1/20 0.56
RXFP1 Q9HBX9 1/20 0.56
SMN1; SMN2 Q16637 3/20 0.55
CDK2 P24941 2/20 0.50
CCNE2 O96020 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8910014 1.00 MEN1 (0.60) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL4278053 0.81 MEN1 (0.68) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL4278065 0.81 MEN1 (0.68) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL4278058 0.81 MEN1 (0.68) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL3282773 0.81 MEN1 (0.61) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL3282776 0.81 MEN1 (0.61) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL29357277 0.81 MAPT (0.67) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL8827139 0.81 MEN1 (0.58) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL29372851 0.81 MAPT (0.67) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL2436925 0.81 MAPT (0.67) MEN1KMT2AMAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663055-A Methods for diagnosing human influenza and 4-position modified chromogenic N-acetylneuraminic acid substrated for use therein OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 1997-09-02 US claimed
EP-0507854-B1 METHODS FOR DIAGNOSING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN SYMEX CORP (US) 1996-11-27 EP claimed
EP-0507854-A4 METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN 1992-10-21 EP claimed
EP-0507854-A1 METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN. SYMEX CORP (US) 1992-10-14 EP claimed
WO-1991010744-A1 CHROMOGENIC 9-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH SYMEX CORP. (US) 1991-07-25 WO claimed
WO-1991009972-A1 METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN SYMEX CORP. (US) 1991-07-11 WO claimed
WO-1991009971-A1 CHROMOGENIC 5-POSITION MODIFIED NEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH SYMEX CORP. (US) 1991-07-11 WO claimed
WO-1991009975-A1 CHROMOGENIC 7- OR 8-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH SYMEX CORP. (US) 1991-07-11 WO claimed
US-5663055-A Methods for diagnosing human influenza and 4-position modified chromogenic N-acetylneuraminic acid substrated for use therein OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 1997-09-02 US disclosed
WO-1991010744-A1 CHROMOGENIC 9-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH SYMEX CORP. (US) 1991-07-25 WO disclosed
WO-1991009971-A1 CHROMOGENIC 5-POSITION MODIFIED NEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH SYMEX CORP. (US) 1991-07-11 WO disclosed
WO-1991009975-A1 CHROMOGENIC 7- OR 8-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH SYMEX CORP. (US) 1991-07-11 WO disclosed